Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Le‐Tian Huang"'
Autor:
Mei-Qi Yang, Shu-Ling Zhang, Li Sun, Le-Tian Huang, Jing Yu, Jie-Hui Zhang, Yuan Tian, Cheng-Bo Han, Jie-Tao Ma
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-23 (2024)
Abstract Immune checkpoint blockade therapy has revolutionized cancer treatment, but resistance remains prevalent, often due to dysfunctional tumor-infiltrating lymphocytes. A key contributor to this dysfunction is mitochondrial dysfunction, characte
Externí odkaz:
https://doaj.org/article/bd16ca19c151423f9d4959ccda936bc3
Autor:
Shu‐Ling Zhang, Jing Yu, Yuan Tian, Jie‐Hui Zhang, Li Sun, Le‐Tian Huang, Jie‐Tao Ma, Cheng‐Bo Han
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
ABSTRACT Purpose To compare the efficacy of first‐line regimens based on programmed cell death (or ligand) [PD‐(L)1] blockade in extensive‐stage small‐cell lung cancer (ES‐SCLC) patients with or without liver metastases (LM), and to identif
Externí odkaz:
https://doaj.org/article/4f4d3c62a1a74e999b28525cf4eb0040
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Purpose To determine the role and rational application of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant non-small-cell lung cancer (NSCLC
Externí odkaz:
https://doaj.org/article/8181fd1434c0488bb08488721b45b3e6
Publikováno v:
The Journal of Nutrition, Health and Aging, Vol 28, Iss 4, Pp 100184- (2024)
Objectives: The aim of the study was to comprehensively analyze the effects of whey protein (WP)-enriched supplement intake with or without resistance training (RT) in older patients, either from the community or hospital, who were diagnosed with sar
Externí odkaz:
https://doaj.org/article/8aa629dafbd54326ac84ddb47d7350af
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background With fast rising incidence, papillary thyroid carcinoma (PTC) is the most common head and neck cancer. Parthenolide, isolated from traditional Chinese medicine, inhibits various cancer cells, including PTC cells. The aim was to in
Externí odkaz:
https://doaj.org/article/e6dd1071491e483b89d2986e31c109ea
Autor:
Ming-Lin Li, Fei Zhang, Yi-Yang Chen, Han-Yong Luo, Zi-Wei Quan, Yi-Fei Wang, Le-Tian Huang, Jia-He Wang
Publikováno v:
Frontiers in Human Neuroscience, Vol 17 (2023)
Primary headache is a very common and burdensome functional headache worldwide, which can be classified as migraine, tension-type headache (TTH), trigeminal autonomic cephalalgia (TAC), and other primary headaches. Managing and treating these differe
Externí odkaz:
https://doaj.org/article/e145854c4108447c910b864f07ea2f3d
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Parthenolide has anti-inflammatory, immunomodulatory and anti-cancer activities. But its effect on thyroid cancer cells is still largely unknown. Methods Label-free quantitative proteomics and bioinformatics analysis were used to
Externí odkaz:
https://doaj.org/article/2eaaea54b4144a798017b51127604f02
Autor:
Xiao-Hang Wang, Shou-Bin Li, Ying-Tao Jiang, Amit Kumar Singh, Bi-Yun Ma, Le-Tian Huang, Mei Yang, Fen Guo
Publikováno v:
Journal of Electronic Science and Technology, Vol 20, Iss 4, Pp 100181- (2022)
When an inaudible sound covert channel (ISCC) attack is launched inside a computer system, sensitive data are converted to inaudible sound waves and then transmitted. The receiver at the other end picks up the sound signal, from which the original se
Externí odkaz:
https://doaj.org/article/97d9284317ed4377b83504169cd0c8f5
Autor:
Ruo-Lin Gao, Jun Song, Li Sun, Zhi-Xuan Wu, Xiao-Fang Yi, Shu-Ling Zhang, Le-Tian Huang, Jie-Tao Ma, Cheng-Bo Han
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Purpose: Immune checkpoint and antiangiogenic inhibitors have a potentially synergistic antitumor effect. We aimed to assess the efficacy and safety of immunotherapy in combination with antiangiogenesis therapy with or without chemotherapy in patient
Externí odkaz:
https://doaj.org/article/444bffd71de945598a60952a4a84ee75
Autor:
Le-Tian Huang, Rui Cao, Yan-Ru Wang, Li Sun, Xiang-Yan Zhang, Yi-Jia Guo, Jian-Zhu Zhao, Shu-Ling Zhang, Wei Jing, Jun Song, Cheng-Bo Han, Jietao Ma
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background In the era of immunotherapy, it is still unclear which is the best first-line therapy for patients with oncogenic driver negative advanced non-squamous non-small cell lung cancer (NS-NSCLC) who cannot tolerate immunotherapy, or su
Externí odkaz:
https://doaj.org/article/728d92872bbc41228b47b7d7eda362e4